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ABSTRACT 
Mucormycosis is a rarely encountered invasive fungal infection with high mortality.Solid organ transplantation is one of 
the risk factors for mucormycosis. Mucormycosis can be classified in six different groups according to the anatomical 
localization; rhinocerebral, pulmonary, cutaneous, gastrointestinal, disseminated, and other less common involvements. 
This paper presented a mucormycosis case with rhinoorbitocerebral involvementin a renal transplantation receiver, 
which manifested with orbital apex syndrome.    
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ÖZET 
Mukormikozis nadir görülen mortalitesi yüksek invaziv bir mantar enfeksiyonudur. Solid organ transplantasyonu 
mukormikoz için risk faktörlerinden birisidir. Mukormikoz anatomik yerleşim yerleri temel alındığında; rinoserebral, 
pulmoner, kutanöz, gastrointestinal, dissemine ve sık rastlanılmayan diğer tutulumlar olmak üzere altı farklı grup olarak 
sınıflandırılabilmektedir. Bu yazıda böbrek transplantasyonu alıcısında orbital apeks sendromu ile prezente olan rino-
orbito-serebral tutulumu olan mukormikoz olgusu sunulmuştur.   
Anahtar kelimeler: Mukormikoz, orbital apeks sendromu, solid organ transplantasyonu. 
INTRODUCTION 
 Mucormycosis, which is caused by the 
members of Mucorales team, is a fungal infection 
with high mortality. Mucormycosis infection occurs 
due to inhalation of sporangiospores of fungi or by 
direct inoculation in the skin and/or mucosa with 
impaired integrity. Nonetheless, mucormycosis is 
characterized by thrombus and tissue necrosis, 
which occur due to the invasion of fungal hypha 
into the vascular configurations3. Risk factors for 
the disease include immune suppression such as 
diabetic ketoacidosis, chronic renal insufficiency,  
 
solid organ or bone marrow stem cell 
transplantation, burnt, and hematological cancers, 
as well as excessive iron load (desferroxamine 
use) and impaired skin integrity.  
 Orbital apex syndrome (OAS), which is one of 
the atypical clinical pictures of mucormycosis, is 
characterized by sudden loss of vision, 
ophthalmoplegia, proptosis, optic atrophy, and 
diplopia due to the involvement of cranial nerves II, 
III, IV, VII and ophthalmic branch of cranial nerve 
V1. 
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 This paper presented a rhinoorbitaocerebral 
mucormycosis case that manifested with OAS, 
atypical clinical pictureand resulted in mortality, in 
a renal transplantation receiver.  
CASE REPORT  
 It was determined from the anamnesis of a 
35-year-old male patient, who received renal 
transplantation in February 2013 from his ABO-
match and HLA-mismatch brother, that he had 
hypertension and received dialysis for 3 times a 
weekin the last month. In the patient, whose panel 
reactive antigen was negative, cold ischemia 
duration was 85 minutes. B-cell cross-match was 
borderline positive in the tissue typing performed 
prior to the surgery. It was determined that the 
patient received antithymocyte immunoglobulin 
(ATG, Fresenius) therapy at a dose of 400 mg/day 
during surgery and in the first 3 days after renal 
transplantation.It was determined that methyl 
prednisolone was administered at a dose of 1000 
mg/day on the days before and after 
transplantation and that steroid therapy was 
commenced at a dose 90 mg on the first day after 
transplantation and continued for a week by 
gradually decreasing the dose by 20 mg each day. 
It was also learned that mycophenolate sodium 
was commenced at a dose of 720 mg/day on the 
operation day and tacrolimus was included in the 
therapy at a dose of 0.1-0.2 mg/kg/day on the 
postoperative 4th day. It was determined that urine 
output was 500 ml/hour in early period after 
surgery and that renal functions began to be 
improved. Post-transplantation control revealed 
normal renal doppler ultrasonography and 
scintigraphy. 
 On the postoperative day 14, the patient 
complained about pain and swelling around the left 
eye, paresthesia on the left side of his face, ptosis 
in the left eyelid, diplopia and decreased hearing in 
the left ear. On his physical examination, body 
temperature was 36.5°C, BP was 130/90 mm/Hg, 
conscious was open, and he was cooperated and 
oriented, whereas there were left peripheral facial 
paralysis, proptosis and exophthalmos in the left 
eye together with chemosis, light reflex was 
negative, there was total ophthalmoplegia 
(complete paralysis of left nervus oculomotorius, n. 
trochlearis and n. abducens) and no gag reflex in 
the left soft palate. A black appearance consistent 
with tissue necrosis was determined in the soft and 
hard palates. Results of laboratory analyses were 
as follows; hemoglobin: 8 g/dL, leukocyte: 
16.300/mm3, thrombocyte: 376.000 K/mm3, C-
reactive protein > 211 mg/L, erythrocyte 
sedimentation rate 111 mm/hour, blood urea 
nitrogen 66 mg/dL, and creatinine 2.2 mg/dL. The 
patient, in whom mucormycosis was considered as 
the pre-diagnosis, underwent computed 
tomography (CT) of paranasal sinuses and non-
contrast-enhanced cranial and orbital magnetic 
resonance imaging (MRI) due to elevation in renal 
function tests. Paranasal CT revealed soft tissue 
densities predominantly in the form of mucosal 
thickening in the left ethmoid cell extending also 
into the nasal cavity and an appearance consistent 
with mild mucosal thickening also in the left 
maxillary sinus (Figure 1a and 1b). No acute 
pathology was observed on cranial MRI. Orbital 
MRI revealed mild proptotic appearance in the left 
globe, linear signal increase in T2 sequences in 
the lateral aspect of globeand around the optic 
nerve and in the retrobulbar adipose tissue, as well 
as pathological signal changes in the retrobulbar 
adipose tissue in the medial aspect and mucosal 
thickening in the left ethmoid cells (Figure 2 ).  
 Being considered to have mucormycosis 
based on existing clinical and radiological findings, 
the case underwent endoscopic sinus surgery in 
the Department of Ear Nose Throat (ENT) 
Diseases. Black necrotic tissues filling nasal cavity 
and sinuses that were consistent with 
mucormycosis were removed. After surgery, 
intravenous 5 mg/kg/day liposomal amphotericin B 
(LAmB) and 2 g/day meropenem were 
commenced. Histopathological examination of 
necrotic tissue removed during operation revealed 
findings consistent with mucormycosis. 
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Zygomycetes spp. growth was detected in fungal 
culture of tissue sample. All immunosuppressive 
drugs that the patient has been receiving were 
discontinued. On the 8th day of antifungal therapy, 
the patient underwent cranial and orbital MRI due 
to impaired consciousness. MRI demonstrated 
notable enhancement in the left exophthalmos, 
increase in the antero-posterior size of left globe, 
thickening in the left conal muscles as well as 
signal increment in the T2 A sequence, fouling 
increment in the retrobulbar adipose tissue, 
defective areas in ethmoidal cells secondary to 
surgery, and an appearance consistent with 
notable progression of sinusitis (Figure 3).  
 Since the disease picture showed clinical and 
radiological progression, the dose of LAmB was 
switched to 7 mg/kg/day, all immunosuppressive 
drugs were discontinued, and parenteral linezolid 
1200 mg/kg/day was included in treatment. 
Because of inadequate response to treatment, left 
orbital exenteration was performed. On 
histopathological examination, the surgical tissue 
sample was found consistent with mucormycosis 
and Zygomycetes spp. was isolated from fungal 
culture. Despite overall supportive treatments, the 
patient died on the 3rd week of antifungal therapy. 
  
Figure 1a and b. On paranasal sinus CT; mucosal thickening in the left ethmoidal cells and in the left maxillary sinus 
extending into the nasal cavity (white arrow). 
 
Figure 2. On orbital MRI; mild proptotic appearance in the left globe, linear signal increment around the optic nerve and 
retrobulbar adipose tissue in T2 sequence (empty arrow); mucosal thickening in the left ethmoidal cells (filled arrow). 
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Figure 3. On control MRI; notable worsening in the left exophthalmos, increase in the anteroposterior size of the left 
globe, thickening and signal increment in the left conal muscles, more apparent pathological signal changes in the 
retrobulbar adipose tissue (empty arrow), defective areas secondary to surgery in the left nasal cavity and ethmoid cells 
and remarkable progression of sinusitis (filled arrow). 
DISCUSSION  
 Mucormycosis is a rarely encountered 
opportunist fungal infection and Rhizopus, 
Lichtheimia, Mucor and Rhizomucor are the 
leading causes of this infection. The prevalence of 
this infection is 0.2-1.2%in the patients that 
underwent renal transplantation4,5. Chronic 
immunosuppression, frequent use of broad-
spectrum antibiotics, concomitant metabolic 
disorders such as uremia, and diabetes mellitus 
that is developed after transplantation enhance the 
risk of mucormycosis in renal transplantation 
patients. In such patients, pulmonary, 
disseminated, gastrointestinal and most commonly 
rhinocerebral involvements may be seen6. 
Mucormycosis infection begins with transportation 
of fungal spores to paranasal sinuses via 
inhalation. Spores that evade phagocytosis invade 
vascular endothelium and cause necrosis, 
thrombus and infarction7. As the consequence, 
necrotic lesions occur in the nasal mucosa and 
hard palate and then necrosis extends to orbital 
and cranial tissues. Spread may occur either via 
direct neighborhood or via embolus from 
surrounding vasculatures depending on necrosis. 
Rhinoorbitacerebral involvement is a rare but the  
 
most important clinical manifestation of 
mucormycosis with high mortality rate and usually 
develops in the patients with diabetes mellitus or 
immune system defect8. 
 Neutrophils and macrophages play important 
role in defensing against mucormycosis. Whilst 
macrophages kill the spores in the cell by oxidative 
mechanism, neutrophils damage fungal hyphae by 
extracellular mechanisms. Therefore, inadequate 
neutrophil count in circulation (neutropenia) or 
impaired phagocytosis function (steroid therapy or 
diabetes) poses a risk for this infection9. We think 
that, immunosuppressive therapy commenced for 
renal transplantation might have caused 
mucormycosis in the present case. 
 OAS, which is one of the atypical clinical 
pictures of mucormycosis, is a rarely encountered 
syndrome developed due to the involvement of 
cranial nerves II, III, IV, VI and ophthalmic branch 
of the cranial nerve V, and it is characterized by 
sudden loss of vision, ophthalmoplegia, proptosis, 
optic atrophy and diplopia1. This syndrome is 
caused by tumors, inflammatory diseases such as 
SLE and sarcoidosis, fungal infections such as 
aspergillosis and mucormycosis, bacterial 
infections, iatrogenic/trauma, and vascular 
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diseases10. Mucormycosis should be suspected as 
the cause of OAS determined in 
immunosuppressed patients, particularly in 
diabetics, and must be promptly diagnosed and 
treated. 
 Diagnosis requires combined use of clinical, 
mycological, pathological and radiological 
methods. In the present case, endoscopic sinus 
surgery was performed because of mucormycosis 
suspected based on clinical and radiological 
findings, and treatment was started. Definite 
diagnosis of mucormycosis was made by 
histopathological examination of tissue removed by 
endoscopic sinus surgery and isolation of the 
agent in culture. Since surgical debridement 
accounts for the substantial proportion of treatment 
in mucormycosis, tissue samples removed from 
the patients must undergo histopathological 
examination and evaluated by culture.  
 Early diagnosis, elimination of the underlying 
predisposing condition, removal of infected tissue 
by surgical debridement and appropriate antifungal 
therapy are of great importance in the treatment of 
mucormycosis. The present patient case died 
despite discontinuation of immunosuppressive 
agents, commencement of antifungal therapy, 
surgical debridement and left orbital exenteretion. 
CONCLUSIONS 
 Today, the number of patients that undergo 
solid organ transplantation is gradually increasing 
in line with advancement in the field of medicine 
and immunosuppressive drugs. Mucormycosis, 
which is an opportunist and life-threatening fungal 
infection, is frequently encountered in these 
patients. Early diagnosis and treatment of this 
disease with high mortality is life-saving. Therefore, 
mucormycosis should certainly be considered in 
the differential diagnosis in the patients that 
underwent solid organ transplantation and have 
orbital apex syndrome.  
REFERENCES 
1. A Turan MN, Tatar E, Yaprak M, Arda B, Kitiş Ö, 
Metin DY et al. A mucormycosis case presented with 
orbital apex syndrome and hemiplegia in a renal 
transplant patient. Int Urol Nephrol. 2012. 
2. Demiroglu YZ, Turunc T, Erkan NB, Alkan Ö, Alıskan 
HE, Colakoglu S et al. Rhinocerebral Mucormycosis 
Treated with Posaconazole: A Case Report. Klimik 
Dergisi. 2010;23:130-3. 
3. Sun HY, Singh N. Mucormycosis: its contemporary 
face and management strategies. Lancet Infect Dis. 
2011;11:301-11. 
4. Chkhotua A, Yussim A, Tovar A, Weinberger M, 
Sobolev V, Bar-Nathan N et al. Mucormycosis of the 
renal allograft: case report and review of the 
literature. Transpl Int. 2001;14:438-41. 
5. Nampoory MR, Khan ZU, Johny KV, Constandi JN, 
Gupta RK, Al-Muzairi I et al. Invasive fungal 
infections in renal transplant recipients. J Infect. 
1996;33:95-101. 
6. Brown J. Zygomycosis: an emerging fungal infection. 
Am J Health Syst Pharm. 2005;62:2593-6.  
7. Wali U, Balkhair A, Al-Mujaini A. Cerebro-rhino orbital 
mucormycosis: an update. J Infect Public Health. 
2012;5:116-26. 
8. Koc Z, Koc F, Yerdelen D, Ozdogu H. Rhino-orbital-
cerebral mucormycosis with different cerebral 
involvements: infarct, hemorrhage, and 
ophthalmoplegia.Int J Neurosci. 2007;117:1677-90. 
9. Spellberg B, Kontoyiannis DP, Fredricks D, Morris 
MI, Perfect JR, Chin-Hong PV et al. Risk factors for 
mortality in patients with mucormycosis. Med Mycol. 
2012;50:611-8. 
10. Yeh S, Foroozan R. Orbital apex syndrome. Curr 
Opin Ophthalmol. 2004;15:490-8. 
 
 
 
 
 388 
Kurşun et al  Cukurova Medical Journal  
 
       Yazışma Adresi / Address for Correspondence: 
       Dr. Ebru Kurşun 
       Başkent University Medical Faculty,  
       Department of Infectious Diseases 
       Yüreğir, ADANA 
       E-mail: ebrukursun@hotmail.com   
 
       Geliş tarihi/Received on : 19.03.2014 
       Kabul tarihi/Accepted on: 21.04.2014 
 
 
 
 
 
 
 
 
 
 389 
